P3 Health Partners(PIII)
$2.15-0.04 (-1.83%)
PIII
P3 Health Partners financials statements
$2.15
At close:-0.04 (-1.83%)
Want to see PIII full AI Analyst Report?
P3 Health Partners (PIII) Ratios
175 Followers
P3 Health Partners Ratios
PIII's free cash flow for Q3 2026 was $-685.00K. For the 2026 fiscal year, PIII's free cash flow was increased by $0.00 and operating cash flow was $-685.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.24 | 0.37 | 0.55 | 0.42 | 1.01 |
| Quick Ratio | 0.24 | 0.37 | 0.55 | 0.42 | 1.01 |
| Cash Ratio | 0.05 | 0.08 | 0.12 | 0.08 | 0.71 |
| Solvency Ratio | -0.08 | -0.08 | 0.07 | -0.52 | -0.49 |
| Operating Cash Flow Ratio | -0.17 | -0.22 | -0.25 | -0.52 | -0.33 |
| Short-Term Operating Cash Flow Coverage | -2.03 | -1.69 | 0.00 | -78.76 | -18.34 |
| Net Current Asset Value | $ -663.79M | $ -449.75M | $ -261.29M | $ -253.39M | $ -100.08M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.43 | 0.21 | 0.14 | 0.12 | 0.04 |
| Debt-to-Equity Ratio | -1.84 | 2.19 | 0.88 | 18.37 | 0.34 |
| Debt-to-Capital Ratio | 2.20 | 0.69 | 0.47 | 0.95 | 0.25 |
| Long-Term Debt-to-Capital Ratio | 3.12 | 0.54 | 0.43 | 0.94 | 0.23 |
| Financial Leverage Ratio | -4.23 | 10.32 | 6.06 | 149.77 | 8.64 |
| Debt Service Coverage Ratio | -1.84 | -2.32 | -5.24 | -112.49 | -12.91 |
| Interest Coverage Ratio | -4.91 | -14.46 | -10.51 | -136.87 | -17.61 |
| Debt to Market Cap | 23.96 | 4.74 | 0.87 | 1.26 | 0.29 |
| Interest Debt Per Share | 103.98 | 64.85 | 74.09 | 143.03 | 123.50 |
| Net Debt to EBITDA | -1.43 | -0.64 | -1.09 | -0.06 | 0.26 |
| Profitability Margins | |||||
| Gross Profit Margin | -9.89% | 100.00% | 100.00% | 100.00% | -4.82% |
| EBIT Margin | -18.23% | -18.92% | -13.25% | -147.53% | -30.33% |
| EBITDA Margin | -12.46% | -13.18% | -6.40% | -139.21% | -28.97% |
| Operating Profit Margin | -18.53% | -21.37% | -13.26% | -148.73% | -29.49% |
| Pretax Profit Margin | -22.00% | -20.39% | -14.51% | -148.62% | -32.06% |
| Net Profit Margin | -10.14% | -9.05% | -4.56% | -25.74% | -24.55% |
| Continuous Operations Profit Margin | -22.14% | -20.69% | -14.72% | -148.79% | -32.06% |
| Net Income Per EBT | 46.08% | 44.40% | 31.44% | 17.32% | 76.58% |
| EBT Per EBIT | 118.78% | 95.43% | 109.41% | 99.92% | 108.72% |
| Return on Assets (ROA) | -22.53% | -17.34% | -6.71% | -30.81% | -6.62% |
| Return on Equity (ROE) | 95.31% | -178.90% | -40.65% | -4614.40% | -57.20% |
| Return on Capital Employed (ROCE) | -242.67% | -111.73% | -29.90% | -245.78% | -8.68% |
| Return on Invested Capital (ROIC) | -172.80% | -91.09% | -29.76% | -245.17% | -8.66% |
| Return on Tangible Assets | -90.09% | -64.98% | -29.74% | -214.92% | -71.61% |
| Earnings Yield | -1296.79% | -415.82% | -46.47% | -353.08% | -53.46% |
| Efficiency Ratios | |||||
| Receivables Turnover | 15.78 | 11.98 | 10.43 | 13.19 | 12.41 |
| Payables Turnover | 19.66 | 0.00 | 0.00 | 0.00 | 122.16 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 432.45 | 261.68 | 52.80 | 51.10 | 42.36 |
| Asset Turnover | 2.22 | 1.92 | 1.47 | 1.20 | 0.27 |
| Working Capital Turnover Ratio | -4.03 | -6.73 | -9.23 | -15.00 | 942.48 |
| Cash Conversion Cycle | 4.57 | 30.46 | 35.01 | 27.68 | 26.41 |
| Days of Sales Outstanding | 23.13 | 30.46 | 35.01 | 27.68 | 29.40 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 18.56 | 0.00 | 0.00 | 0.00 | 2.99 |
| Operating Cycle | 23.13 | 30.46 | 35.01 | 27.68 | 29.40 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -27.91 | -37.92 | -40.06 | -151.54 | -79.93 |
| Free Cash Flow Per Share | -27.91 | -37.92 | -41.02 | -154.23 | -84.04 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -41.61 | -56.43 | -19.49 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -41.61 | -56.43 | -19.49 |
| Operating Cash Flow Coverage Ratio | -0.32 | -0.66 | -0.61 | -1.17 | -0.72 |
| Operating Cash Flow to Sales Ratio | -0.06 | -0.07 | -0.06 | -0.12 | -0.10 |
| Free Cash Flow Yield | -799.72% | -337.09% | -62.63% | -167.64% | -23.87% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.08 | -0.24 | -2.15 | -0.28 | -1.87 |
| Price-to-Sales (P/S) Ratio | 0.01 | 0.02 | 0.10 | 0.07 | 0.46 |
| Price-to-Book (P/B) Ratio | -0.07 | 0.43 | 0.87 | 13.07 | 1.07 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.13 | -0.30 | -1.60 | -0.60 | -4.19 |
| Price-to-Operating Cash Flow Ratio | -0.13 | -0.30 | -1.64 | -0.61 | -4.40 |
| Price-to-Earnings Growth (PEG) Ratio | 0.02 | -0.00 | 0.02 | -0.00 | -0.01 |
| Enterprise Value Multiple | -1.49 | -0.81 | -2.62 | -0.11 | -1.32 |
| Enterprise Value | 271.28M | 160.02M | 212.64M | 165.59M | 244.26M |
| EV to EBITDA | -1.49 | -0.81 | -2.62 | -0.11 | -1.32 |
| EV to Sales | 0.19 | 0.11 | 0.17 | 0.16 | 0.38 |
| EV to Free Cash Flow | -2.97 | -1.45 | -2.73 | -1.29 | -3.50 |
| EV to Operating Cash Flow | -2.97 | -1.45 | -2.80 | -1.31 | -3.67 |
| Tangible Book Value Per Share | -193.53 | -146.29 | -122.80 | -274.65 | -97.91 |
| Shareholders’ Equity Per Share | -47.49 | 26.15 | 74.88 | 7.04 | 328.96 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | -0.01 | -0.01 | -0.00 | 0.00 |
| Revenue Per Share | 446.34 | 516.69 | 667.22 | 1262.02 | 766.45 |
| Net Income Per Share | -45.26 | -46.78 | -30.44 | -324.84 | -188.17 |
| Tax Burden | 0.46 | 0.44 | 0.31 | 0.17 | 0.77 |
| Interest Burden | 1.21 | 1.08 | 1.10 | 1.01 | 1.06 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.07 | 0.08 | 0.10 | 0.15 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.28 | 0.35 | 0.41 | 0.47 | 0.42 |
Currency in USD

